European shares rise, Genmab jumps on drug trial results, bond yields dip
European shares climbed towards one-week highs, led by gains in healthcare stocks after Genmab announced upbeat drug-trial results. Euro zone bond yields stabilized after recent gains driven by fiscal and inflation concerns.
European shares rose towards one-week highs on Tuesday, supported by gains in healthcare stocks after Genmab's upbeat drug-trial results, while euro zone bond yields took a breather after rallying on fiscal and inflation concerns. 8.